As the world continues to embrace the myriad benefits of cannabis, a surprising new frontier is emerging in the realm of animal care: wildlife sanctuaries and zoos. These institutions, dedicated to the conservation and well-being of diverse species, are increasingly exploring the potential of cannabis therapeutics to improve the health and quality of life for their animal residents.
A pioneering force in this movement is VetCBD, a company that specializes in creating high-quality CBD products for animals. VetCBD has made significant strides in integrating cannabis therapeutics into animal care, forging partnerships with wildlife sanctuaries and zoos to conduct CBD trials and gather valuable data.
One of VetCBD’s most notable partnerships is with the Cali Zoo in Colombia. This innovative collaboration has seen over 50 different species benefit from cannabis therapeutics, with remarkable results. From alleviating discomfort in aging animals to reducing stress in those affected by captivity, the use of CBD has shown promising potential across a wide range of conditions.
At the Cali Zoo, animals from various species have experienced the benefits of CBD. For instance, elderly big cats suffering from issues with mobility have found relief, allowing them to move more freely and comfortably. Primates, often prone to stress in captivity, have exhibited calmer behavior and improved social interactions after receiving CBD treatments. Even smaller creatures, such as an electric eel and a poison dart frog, have shown positive responses, demonstrating the broad applicability of cannabis therapeutics in the animal kingdom.
The success of the Cali Zoo’s program has sparked interest and hope among other wildlife care institutions worldwide. The evidence gathered from these trials is helping to build a robust case for the use of cannabis in animal healthcare, paving the way for more widespread adoption.
VetCBD is not limiting the groundbreaking work in Colombia. The company is also actively partnering with wildlife sanctuaries and zoos across the United States to perform CBD trials. These collaborations aim to replicate the success seen at the Cali Zoo and further explore the therapeutic benefits of cannabis for a diverse array of species.
In the U.S., zoos and sanctuaries are home to animals with varied health challenges. By conducting controlled trials and gathering comprehensive data, VetCBD and its partners hope to establish standardized protocols for the use of CBD in animal care. This research could lead to significant advancements in managing issues with mobility, stress, discomfort, and other health issues in wildlife.
The integration of cannabis therapeutics into wildlife care represents a holistic approach that prioritizes the well-being of animals. Unlike traditional pharmaceuticals, which can often have harsh side effects, CBD offers a natural and gentle alternative. As more sanctuaries and zoos adopt this approach, the potential for improved animal welfare is immense.
Moreover, the use of CBD aligns with the broader goals of conservation and ethical animal treatment. By enhancing the health and quality of life for animals in captivity, these institutions can better fulfill their mission of protecting and preserving endangered species.
The partnership between VetCBD and wildlife care institutions marks an exciting development in the field of animal healthcare. As research progresses and more success stories emerge, the use of cannabis therapeutics in wildlife sanctuaries and zoos is likely to become more prevalent.
For now, the inspiring work being done at the Cali Zoo and across the United States serves as a testament to the potential of cannabis to transform the lives of animals. With continued collaboration, innovation, and dedication, the future looks bright for the integration of CBD into wildlife care.
As we continue to explore and understand the benefits of cannabis, both humans and animals stand to gain from its therapeutic properties. VetCBD is at the forefront of this exciting journey, leading the way towards a more compassionate and effective approach to animal health.
Zoo Logic with animal trainer, zoo advocate, and ZOOmility author, Dr. Grey Stafford, is a weekly conversation with zoo, aquarium, and animal experts about Nature, wildlife, pets, animal training with positive reinforcement, health and welfare, research, conservation, and education, sustainability, zoo politics, activism and legislation, and all things animals! On Zoo Logic, we’ll go behind the scenes with animal professionals and influencers from around the world to explore the latest Zoos News and issues affecting wildlife, wild places, and people. Communicating with humor, cool stories, and candor, we’ll discover the interdependent connection between civilization, conservation, and commerce.
Dr. Tim Shu, founder and CEO of VetCBD, leads a California company specializing in cannabis products for animals. As the legal cannabis industry grows in the U.S., questions about the safety and effectiveness of CBD and low-THC products arise. Dr. Shu highlights cannabis’s long history of medicinal use and research showing cannabinoids’ therapeutic effects on chronic pain, stress, inflammation, nausea, and seizures in animals. He advocates for using all available tools to improve animal health and quality of life, especially as zoo animals live longer than in the wild.
https://zoologic.libsyn.com/cannabis-for-companion-and-exotic-animals
These statements have not been evaluated by the Food and Drug Administration. These products is not intended to diagnose, treat, cure, or prevent any disease.
The world of pet wellness is always evolving. Get notified about new product launches, news, and more!
Due to state laws, we are unable to ship product to Idaho, Kansas, South Dakota, and Nebraska.
VetCBDÂ products are made using hemp containing less than 0.3% THC.
